Bristol-Myers Squibb Company Profile (NYSE:BMY)

About Bristol-Myers Squibb

Bristol-Myers Squibb logoBristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. It offers products for a range of therapeutic classes, which include virology, including human immunodeficiency virus (HIV) infection; oncology; immunoscience; cardiovascular, and neuroscience. Its late-stage investigational compounds that are in Phase III clinical trials include Beclabuvir, BMS-663068 and Prostvac.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: Pharmaceuticals
  • Exchange: NYSE
  • Symbol: BMY
  • CUSIP: 11012210
Key Metrics:
  • Previous Close: $55.56
  • 50 Day Moving Average: $57.97
  • 200 Day Moving Average: $67.43
  • 52-Week Range: $55.02 - $77.12
  • Trailing P/E Ratio: 32.49
  • Foreward P/E Ratio: 18.49
  • P/E Growth: 1.10
  • Market Cap: $92.83B
  • Outstanding Shares: 1,670,858,000
  • Beta: 0.61
Profitability:
  • Net Margins: 16.63%
  • Return on Equity: 24.92%
  • Return on Assets: 11.53%
Debt:
  • Debt-to-Equity Ratio: 0.44%
  • Current Ratio: 1.56%
  • Quick Ratio: 1.38%
Additional Links:
Companies Related to Bristol-Myers Squibb:

Analyst Ratings

Consensus Ratings for Bristol-Myers Squibb (NYSE:BMY) (?)
Ratings Breakdown: 2 Sell Ratings, 11 Hold Ratings, 8 Buy Ratings
Consensus Rating:Hold (Score: 2.29)
Consensus Price Target: $68.24 (22.99% upside)

Analysts' Ratings History for Bristol-Myers Squibb (NYSE:BMY)
Show:
DateFirmActionRatingPrice TargetDetails
9/20/2016Citigroup Inc.Lower Price TargetBuy$75.00 -> $70.00View Rating Details
9/12/2016Goldman Sachs Group Inc.Reiterated RatingBuyView Rating Details
9/12/2016Jefferies GroupReiterated RatingHold -> Hold$69.00 -> $57.00View Rating Details
9/9/2016Barclays PLCLower Price TargetEqual Weight$75.00 -> $65.00View Rating Details
9/7/2016Leerink SwannReiterated RatingBuy$75.00View Rating Details
9/3/2016BMO Capital MarketsReiterated RatingMarket Perform$60.00View Rating Details
8/25/2016Morgan StanleyReiterated RatingNeutral -> HoldView Rating Details
8/15/2016Credit Suisse Group AGReiterated RatingHold$63.00View Rating Details
8/13/2016ArgusReiterated RatingBuy$90.00View Rating Details
8/11/2016Berenberg BankDowngradeBuy -> Hold$80.00 -> $70.00View Rating Details
8/11/2016Sanford C. BernsteinReiterated RatingMarket Perform$79.00 -> $65.00View Rating Details
8/10/2016William BlairReiterated RatingBuyView Rating Details
8/8/2016Piper Jaffray Cos.Reiterated RatingNeutral$69.00 -> $65.00View Rating Details
8/8/2016Deutsche Bank AGLower Price TargetHold$68.00 -> $62.00View Rating Details
8/5/2016SunTrust Banks Inc.DowngradeBuy -> Neutral$86.00 -> $68.00View Rating Details
5/23/2016Hilliard LyonsInitiated CoverageNeutralView Rating Details
5/19/2016JPMorgan Chase & Co.Reiterated RatingOverweightView Rating Details
4/6/2016Societe GeneraleInitiated CoverageSell$48.00View Rating Details
12/18/2015Atlantic SecuritiesInitiated CoverageUnderweight$57.00View Rating Details
12/14/2015Cowen and CompanyReiterated RatingOutperform$75.00 -> $100.00View Rating Details
12/2/2015GuggenheimUpgradeNeutral -> Buy$82.00View Rating Details
11/28/2014FBR & CoReiterated RatingPositiveView Rating Details
10/27/2014MKM PartnersBoost Price TargetSell$34.00 -> $36.00View Rating Details
(Data available from 9/26/2014 forward)

Earnings

Earnings History for Bristol-Myers Squibb (NYSE:BMY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/25/2016        
7/28/2016Q216$0.66$0.69$4.60 billion$4.90 billionViewListenView Earnings Details
4/28/2016Q116$0.65$0.74$4.19 billion$4.39 billionViewListenView Earnings Details
1/28/2016Q415$0.28$0.38$4.07 billion$4.29 billionViewListenView Earnings Details
10/27/2015Q315$0.35$0.39$3.83 billion$4.07 billionViewListenView Earnings Details
7/23/2015Q215$0.36$0.53$3.68 billion$4.16 billionViewListenView Earnings Details
4/28/2015Q115$0.50$0.71$3.80 billion$4.04 billionViewN/AView Earnings Details
1/27/2015Q414$0.41$0.46$4.02 billion$4.26 billionViewN/AView Earnings Details
10/24/2014Q314$0.42$0.45$3.80 billion$3.92 billionViewListenView Earnings Details
7/24/2014Q214$0.44$0.48$3.85 billion$3.89 billionViewListenView Earnings Details
4/29/2014Q114$0.43$0.46$3.89 billion$3.81 billionViewListenView Earnings Details
1/24/2014Q413$0.43$0.53$4.30 billion$4.44 billionViewListenView Earnings Details
10/23/2013Q313$0.44$0.46$4.02 billion$4.07 billionViewListenView Earnings Details
7/25/2013Q2 2013$0.45$0.44$4.07 billion$4.05 billionViewListenView Earnings Details
4/25/2013Q1 2013$0.41$0.41$3.88 billion$3.83 billionViewListenView Earnings Details
1/24/2013Q4 2012$0.42$0.47$4.14 billion$4.19 billionViewListenView Earnings Details
10/24/2012$0.42$0.41ViewN/AView Earnings Details
7/25/2012$0.48$0.48ViewN/AView Earnings Details
4/26/2012$0.64$0.64ViewN/AView Earnings Details
1/26/2012$0.55$0.53ViewN/AView Earnings Details
10/27/2011$0.58$0.61ViewN/AView Earnings Details
7/28/2011$0.55$0.56ViewN/AView Earnings Details
4/28/2011$0.53$0.58ViewN/AView Earnings Details
1/27/2011$0.48$0.47ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Bristol-Myers Squibb (NYSE:BMY)
Current Year EPS Consensus Estimate: $2.62 EPS
Next Year EPS Consensus Estimate: $3.00 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.63$0.66$0.64
Q2 20164$0.65$0.69$0.67
Q3 20163$0.61$0.66$0.64
Q4 20163$0.57$0.61$0.59
Q1 20171$0.74$0.74$0.74
Q2 20171$0.80$0.80$0.80
Q3 20171$0.84$0.84$0.84
Q4 20171$0.86$0.86$0.86
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Bristol-Myers Squibb (NYSE:BMY)
Annual Dividend:$1.52
Dividend Yield:2.74%
Dividend Growth:2.90% (3 Year Average)
Payout Ratio:87.36% (Based on Trailing 12 Months of Earnings)
58.02% (Based on Current Year Consensus EPS Estimate)
50.67% (Based on Next Year Consensus EPS Estimate)
Track Record:6 Years of Consecutive Dividend Growth

Dividend History for Bristol-Myers Squibb (NYSE:BMY)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/3/2016quarterly$0.382.02%10/5/201610/7/201611/1/2016
6/7/2016quarterly$0.382.07%6/29/20167/1/20168/1/2016
3/3/2016quarterly$0.382.35%3/30/20164/1/20165/2/2016
12/8/2015quarterly$0.382.22%12/30/20151/4/20162/1/2016
9/17/2015quarterly$0.372.3%9/30/201510/2/201511/2/2015
6/16/2015quarterly$0.372.23%7/1/20157/6/20158/3/2015
3/2/2015quarterly$0.372.39%4/1/20154/6/20155/1/2015
12/9/2014quarterly$0.372.5%12/30/20141/2/20152/2/2015
9/16/2014quarterly$0.362.83%10/1/201410/3/201411/3/2014
6/17/2014quarterly$0.363%7/1/20147/3/20148/1/2014
3/3/2014quarterly$0.362.55%4/2/20144/4/20145/1/2014
12/19/2013quarterly$0.362.7%12/31/20131/3/20142/3/2014
9/17/2013quarterly$0.352.95%10/2/201310/4/201311/1/2013
6/19/2013quarterly$0.353.14%7/2/20137/5/20138/1/2013
3/7/2013quarterly$0.353.74%4/3/20134/5/20135/1/2013
12/4/2012quarterly$0.351/4/20132/1/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Bristol-Myers Squibb (NYSE:BMY)
Insider Ownership Percentage: 0.24%
Institutional Ownership Percentage: 72.91%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/8/2016Lamberto AndreottiDirectorSell21,600$56.87$1,228,392.00View SEC Filing  
8/25/2016Lamberto AndreottiDirectorSell23,200$59.17$1,372,744.00View SEC Filing  
7/8/2016Lamberto AndreottiDirectorSell23,200$74.45$1,727,240.00View SEC Filing  
6/28/2016Lamberto AndreottiDirectorSell23,200$72.14$1,673,648.00View SEC Filing  
6/14/2016John E ElickerSVPSell11,820$72.69$859,195.80View SEC Filing  
5/20/2016Charles A BancroftCFOSell30,201$70.79$2,137,928.79View SEC Filing  
5/16/2016Joseph C CaldarellaSVPSell3,519$72.47$255,021.93View SEC Filing  
5/6/2016Sandra LeungEVPSell72,544$70.39$5,106,372.16View SEC Filing  
5/5/2016Lamberto AndreottiDirectorSell23,200$70.54$1,636,528.00View SEC Filing  
5/3/2016Giovanni CaforioCEOSell34,594$71.31$2,466,898.14View SEC Filing  
5/2/2016Autenried Paul VonSVPSell37,258$71.93$2,679,967.94View SEC Filing  
5/2/2016Lamberto AndreottiDirectorSell234,720$71.88$16,871,673.60View SEC Filing  
5/2/2016Louis S SchmuklerInsiderSell22,218$71.95$1,598,585.10View SEC Filing  
4/5/2016Lamberto AndreottiDirectorSell23,200$65.90$1,528,880.00View SEC Filing  
4/4/2016Lamberto AndreottiDirectorSell11,600$65.79$763,164.00View SEC Filing  
3/9/2016Lamberto AndreottiDirectorSell23,200$65.71$1,524,472.00View SEC Filing  
3/8/2016Lewis B CampbellDirectorSell2,500$66.00$165,000.00View SEC Filing  
3/4/2016Joseph C CaldarellaSVPSell12,962$64.64$837,863.68View SEC Filing  
2/17/2016Giovanni CaforioCEOSell12,040$63.58$765,503.20View SEC Filing  
2/17/2016Sandra LeungEVPSell10,152$63.57$645,362.64View SEC Filing  
2/12/2016Lamberto AndreottiDirectorSell23,200$59.61$1,382,952.00View SEC Filing  
1/5/2016Lamberto AndreottiDirectorSell23,200$67.56$1,567,392.00View SEC Filing  
1/4/2016Lamberto AndreottiDirectorSell11,600$66.93$776,388.00View SEC Filing  
12/15/2015Lamberto AndreottiDirectorSell23,200$69.03$1,601,496.00View SEC Filing  
11/20/2015Lamberto AndreottiDirectorSell23,200$67.39$1,563,448.00View SEC Filing  
10/6/2015Lamberto AndreottiDirectorSell23,200$60.86$1,411,952.00View SEC Filing  
9/3/2015Lamberto AndreottiDirectorSell23,200$59.40$1,378,080.00View SEC Filing  
6/4/2015Joseph C CaldarellaSVPSell16,972$65.71$1,115,230.12View SEC Filing  
3/16/2015Francis M CussEVPSell114,666$67.81$7,775,501.46View SEC Filing  
3/16/2015Louis S SchmuklerInsiderSell12,000$66.96$803,520.00View SEC Filing  
2/17/2015Sandra LeungGeneral CounselSell11,746$60.39$709,340.94View SEC Filing  
2/12/2015Samuel J MoedSVPSell3,880$59.26$229,928.80View SEC Filing  
2/6/2015Samuel J MoedSVPSell21,478$60.15$1,291,901.70View SEC Filing  
1/29/2015Lamberto AndreottiCEOSell90,246$61.14$5,517,640.44View SEC Filing  
1/29/2015Lewis B CampbellDirectorSell2,500$60.89$152,225.00View SEC Filing  
1/29/2015Louis S SchmuklerInsiderSell5,250$60.73$318,832.50View SEC Filing  
12/5/2014Lamberto AndreottiCEOSell75,000$60.31$4,523,250.00View SEC Filing  
10/24/2014Lamberto AndreottiCEOSell50,000$53.00$2,650,000.00View SEC Filing  
10/6/2014Lamberto AndreottiCEOSell50,000$50.99$2,549,500.00View SEC Filing  
9/16/2014Francis M CussEVPSell63,667$50.77$3,232,373.59View SEC Filing  
9/15/2014Giovanni CaforioCOOSell26,691$49.87$1,331,080.17View SEC Filing  
9/10/2014Joseph C CaldarellaSVPSell7,415$51.03$378,387.45View SEC Filing  
9/8/2014Lamberto AndreottiCEOSell50,000$51.05$2,552,500.00View SEC Filing  
8/19/2014Autenried Paul VonSVPSell20,000$49.89$997,800.00View SEC Filing  
7/29/2014Charles A BancroftCFOSell67,621$51.06$3,452,728.26View SEC Filing  
7/28/2014Samuel J MoedSVPSell25,752$49.32$1,270,088.64View SEC Filing  
3/13/2014Joseph CaldarellaSVPSell9,137$55.20$504,362.40View SEC Filing  
3/10/2014Lamberto AndreottiCEOSell100,000$55.52$5,552,000.00View SEC Filing  
3/10/2014Louis SchmuklerInsiderSell8,799$55.81$491,072.19View SEC Filing  
3/5/2014James CorneliusDirectorSell100,000$55.82$5,582,000.00View SEC Filing  
2/28/2014Louis SchmuklerInsiderSell6,088$54.49$331,735.12View SEC Filing  
2/24/2014Giovanni CaforioEVPSell41,563$54.44$2,262,689.72View SEC Filing  
2/19/2014John ElickerSVPSell9,534$54.22$516,933.48View SEC Filing  
2/18/2014Francis CussEVPSell29,800$54.61$1,627,378.00View SEC Filing  
2/14/2014Charles BancroftCFOSell52,963$54.35$2,878,539.05View SEC Filing  
2/14/2014Sandra LeungGeneral CounselSell10,490$54.28$569,397.20View SEC Filing  
2/11/2014Lamberto AndreottiCEOSell86,075$52.66$4,532,709.50View SEC Filing  
2/6/2014Joseph CaldarellaSVPSell35,471$48.90$1,734,531.90View SEC Filing  
2/5/2014Lewis CampbellDirectorSell2,500$48.28$120,700.00View SEC Filing  
2/4/2014James CorneliusDirectorSell100,000$48.90$4,890,000.00View SEC Filing  
7/29/2013James M CorneliusDirectorSell5,000$43.81$219,050.00View SEC Filing  
6/10/2013Autenried Paul VonSVPSell25,000$47.24$1,181,000.00View SEC Filing  
6/6/2013Joseph C CaldarellaSVPSell26,275$46.53$1,222,575.75View SEC Filing  
6/5/2013John E ElickerSVPSell25,997$46.33$1,204,441.01View SEC Filing  
6/4/2013Lamberto AndreottiCEOSell100,000$47.74$4,774,000.00View SEC Filing  
6/4/2013Samuel J MoedSVPSell58,898$47.38$2,790,587.24View SEC Filing  
6/3/2013Elliot SigalEVPSell83,647$48.18$4,030,112.46View SEC Filing  
5/31/2013Beatrice J CazalaEVPSell91,282$47.00$4,290,254.00View SEC Filing  
5/31/2013Giovanni CaforioInsiderSell10,538$47.06$495,918.28View SEC Filing  
5/30/2013Beatrice J CazalaEVPSell22,000$47.00$1,034,000.00View SEC Filing  
5/28/2013Charles A BancroftCFOSell25,000$48.68$1,217,000.00View SEC Filing  
5/28/2013James M CorneliusDirectorSell100,000$47.61$4,761,000.00View SEC Filing  
5/23/2013Beatrice J CazalaEVPSell96,000$46.99$4,511,040.00View SEC Filing  
5/23/2013Giovanni CaforioInsiderSell26,647$46.29$1,233,489.63View SEC Filing  
5/17/2013James M CorneliusDirectorSell225,996$42.99$9,715,568.04View SEC Filing  
5/8/2013James M CorneliusDirectorSell20,000$39.85$797,000.00View SEC Filing  
5/2/2013James M CorneliusDirectorSell20,000$39.76$795,200.00View SEC Filing  
4/11/2013James M CorneliusDirectorSell20,000$41.15$823,000.00View SEC Filing  
3/13/2013James M CorneliusDirectorSell20,000$38.18$763,600.00View SEC Filing  
3/13/2013John E ElickerSVPSell3,409$38.51$131,280.59View SEC Filing  
2/27/2013Giovanni CaforioInsiderSell12,150$37.08$450,522.00View SEC Filing  
2/26/2013James M CorneliusDirectorSell20,000$36.58$731,600.00View SEC Filing  
1/17/2013James M CorneliusDirectorSell20,000$34.33$686,600.00View SEC Filing  
12/28/2012James M CorneliusDirectorSell20,000$32.06$641,200.00View SEC Filing  
10/3/2012James M CorneliusDirectorSell20,000$33.71$674,200.00View SEC Filing  
8/10/2012James M CorneliusDirectorSell10,000$31.81$318,100.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Bristol-Myers Squibb (NYSE:BMY)
DateHeadline
News IconActive Runners - Skyline Medical, (NASDAQ:SKLN), Bristol-Myers Squibb, (NYSE:BMY) - Financial Breaking News (NYSE:BMY)
wsbreakingnews.com - September 26 at 4:06 PM
News Icon2 Stocks Attracting Analyst Attention: Bristol-Myers Squibb Co (NYSE:BMY), Eversource Energy (NYSE:ES) - The Voice Registrar (NYSE:BMY)
voiceregistrar.com - September 26 at 4:06 PM
News IconHC Stocks Broker Alerts! Bioline RX Ltd (BLRX), Bristol-Myers Squibb Co (NYSE:BMY) - share market updates (press release) (NYSE:BMY)
sharemarketupdates.com - September 26 at 8:39 AM
News IconInvestor News: Lawsuit against certain directors of Bristol-Myers Squibb Co (NYSE:BMY) (NYSE:BMY)
www.groundreport.com - September 23 at 3:21 PM
News IconDrug Manufacturers – Major: Bristol-Myers Squibb Company (NYSE:BMY) Position of the day (NYSE:BMY)
twincountynews.com - September 23 at 3:21 PM
marketrealist.com logoGilead Sciences Focuses on a Strong Inorganic Growth Strategy (NYSE:BMY)
marketrealist.com - September 23 at 8:59 AM
News IconBristol-Myers Squibb Company (NYSE:BMY) from Drug Manufacturers – Major – Todays Top Gains (NYSE:BMY)
twincountynews.com - September 22 at 4:03 PM
finance.yahoo.com logoBristol-Myers Squibb to Take Part in Leerink Partners Immuno-Oncology Roundtable Conference (NYSE:BMY)
finance.yahoo.com - September 22 at 4:03 PM
thestreet.com logoBristol-Myers Squibb Stock Is Down, but That Means You Should Buy (NYSE:BMY)
www.thestreet.com - September 22 at 4:03 PM
News IconHC Stocks Zone! Ariad Pharmaceuticals, Inc. (ARIA), Bristol-Myers Squibb Co (NYSE:BMY) - share market updates (press release) (NYSE:BMY)
sharemarketupdates.com - September 22 at 8:08 AM
News Icon$LMT & $BMY - Lockheed Martin Corporation (NYSE:LMT) & Bristol-Myers Squibb Co(NYSE:BMY) Watch List - Money News (NYSE:BMY)
www.newsismoney.com - September 21 at 3:20 PM
News IconBristol-Myers Squibb Co (NYSE:BMY): Price Reaction History - Post Registrar (NYSE:BMY)
postregistrar.com - September 21 at 3:20 PM
publicnow.com logoEuropean Medicines Agency Validates Bristol-Myers Squibb's Type II Variation Application for Opdivo (nivolumab) in Advanced Form of Bladder Cancer (189KB) (NYSE:BMY)
www.publicnow.com - September 21 at 8:27 AM
marketrealist.com logoBristol-Myers Capitalizes on Japanese Markets for Its Cardio Drug (NYSE:BMY)
marketrealist.com - September 21 at 8:27 AM
4-traders.com logoBristol Myers Squibb : Nippon Life Insurance Co Lowers stake in Bristol-Myers Squibb Co (BMY) (NYSE:BMY)
www.4-traders.com - September 20 at 9:47 AM
tmcnet.com logoEuropean Medicines Agency Validates Bristol-Myers Squibb's Type II Variation Application for Opdivo (nivolumab) in Advanced Form of Bladder Cancer (NYSE:BMY)
www.tmcnet.com - September 20 at 9:47 AM
News IconIs Bristol-Myers Squibb Company (NYSE:BMY), a large market cap stock a smart buy? (NYSE:BMY)
twincountynews.com - September 20 at 9:46 AM
News IconBristol-Myers Squibb Awards First “Golden Tickets” for LabCentral to PanTher, Suono Bio (NYSE:BMY)
sports.yahoo.com - September 20 at 9:46 AM
publicnow.com logoEuropean Medicines Agency Validates Bristol-Myers Squibb’s Type II Variation Application for Opdivo (nivolumab) in Advanced Form of Bladder Cancer (NYSE:BMY)
www.publicnow.com - September 20 at 9:46 AM
marketrealist.com logoMultiple Segments of Lung Cancer Create Opportunity for Bristol-Myers Squibb’s (NYSE:BMY)
marketrealist.com - September 20 at 9:46 AM
News IconHigh Market Cap Stock of the Day – Bristol-Myers Squibb Company (NYSE:BMY) (NYSE:BMY)
twincountynews.com - September 19 at 4:46 PM
marketrealist.com logoBristol-Myers Squibb’s Strategic Focus on These Areas Could Boost Overall Growth (NYSE:BMY)
marketrealist.com - September 19 at 4:46 PM
News IconCell biology jobs USA | Associate Scientist position @ Bristol-Myers Squibb (NYSE:BMY)
www.biochemadda.com - September 19 at 8:39 AM
seekingalpha.com logoFinally, Time To Buy Bristol-Myers (NYSE:BMY)
seekingalpha.com - September 19 at 8:39 AM
marketrealist.com logoRoche Goes Up against Bristol-Myers Squibb in Oncology Drug Space (NYSE:BMY)
marketrealist.com - September 19 at 8:39 AM
marketrealist.com logoWhat Analysts Think about Bristol-Myers Squibb (NYSE:BMY)
marketrealist.com - September 19 at 8:39 AM
News IconBristol-Myers Squibb Co (BMY) Stock Rating Upgraded by TheStreet - DailyQuint (NYSE:BMY)
dailyquint.com - September 17 at 3:50 PM
News IconStocks Taking Toll on Investment Valuation: Bristol-Myers Squibb (NYSE:BMY), Anthem (NYSE:ANTM) - Street Wise Report (press release) (blog) (NYSE:BMY)
streetwisereport.com - September 16 at 3:49 PM
News IconAnalysts Valuations For Two Stocks: TD Ameritrade Holding Corp. (NASDAQ:AMTD), Bristol-Myers Squibb Co (NYSE ... - The Voice Registrar (NYSE:BMY)
voiceregistrar.com - September 15 at 3:42 PM
wallstrt24.com logoTrader's Buzzers - Great Basin Scientific, (NASDAQ:GBSN), Bristol-Myers Squibb, (NYSE:BMY), IAMGOLD, (NYSE:IAG) - Wall Street 24 (NYSE:BMY)
wallstrt24.com - September 15 at 3:42 PM
thestreet.com logoJim Cramer's Top Takeaways: Bristol-Myers Squibb, Toll Brothers, Foot Locker - TheStreet.com (NYSE:BMY)
www.thestreet.com - September 15 at 3:42 PM
News IconHC Trending Hot Stocks= Ariad Pharmaceuticals, Inc. (ARIA), Bristol-Myers Squibb Co (NYSE:BMY) - share market updates (press release) (NYSE:BMY)
sharemarketupdates.com - September 15 at 3:42 PM
seekingalpha.com logoBristol-Myers Squibb (BMY) Management Presents at Bank of America Merrill Lynch 2016 Global Healthcare Conference (Transcript) (NYSE:BMY)
seekingalpha.com - September 15 at 12:47 PM
fidaily.com logoBristol-Myers Squibb Company Co (BMY) Ownership Decreased by Macquarie Group Ltd (NYSE:BMY)
www.fidaily.com - September 15 at 12:47 PM
cnbc.com logoCramer: Bristol-Myers is a screaming value buy (NYSE:BMY)
www.cnbc.com - September 14 at 9:05 PM
News IconShares of Fifth Third Bancorp (NASDAQ:FITB) & Bristol-Myers ... - Money News (NYSE:BMY)
www.newsismoney.com - September 14 at 3:53 PM
seekingalpha.com logoBristol-Myers Squibb (BMY) at Bank of America Merrill Lynch 2016 ... - Seeking Alpha (NYSE:BMY)
seekingalpha.com - September 14 at 3:53 PM
seekingalpha.com logoBristol-Myers Squibb (BMY) Management on Morgan Stanley 2016 Global Healthcare Conference - Brokers ... - Seeking Alpha (NYSE:BMY)
seekingalpha.com - September 14 at 5:24 AM
publicnow.com logoEuropean Commission Approves Bristol-Myers Squibb's ORENCIA® (abatacept) for the Treatment of Highly Active and Progressive Disease in Adult Patients with Rheumatoid Arthritis Not Previously Treated with Methotrexate (133KB) (NYSE:BMY)
www.publicnow.com - September 14 at 5:24 AM
istreetwire.com logoStocks Intraday Alert: QUALCOMM Incorporated (QCOM), Bristol ... - iStreetWire (NYSE:BMY)
istreetwire.com - September 13 at 5:43 PM
seekingalpha.com logoBristol-Myers Squibb Has Reached Bottom - Seeking Alpha (NYSE:BMY)
seekingalpha.com - September 13 at 5:43 PM
publicnow.com logoBristol-Myers Squibb’s Response to ICER’s Call for Improvements to its Value Assessment Framework (NYSE:BMY)
www.publicnow.com - September 13 at 8:45 AM
News IconStocks Ringing Investment Alarms: Bristol-Myers Squibb Company (NYSE:BMY), Inovio Pharmaceuticals, Inc ... - Street Wise Report (press release) (blog) (NYSE:BMY)
streetwisereport.com - September 12 at 3:47 PM
News IconBiotechnology Job USA | Technical Lead position @ Bristol-Myers Squibb (NYSE:BMY)
www.biochemadda.com - September 12 at 8:38 AM
News IconOrbimed Advisors Lowers stake in Bristol-Myers Squibb Co (BMY) - National Daily Press (NYSE:BMY)
www.nationaldailypress.com - September 11 at 3:44 PM
News IconOrbimed Advisors Lowers stake in Bristol-Myers Squibb Co (BMY) (NYSE:BMY)
www.nationaldailypress.com - September 11 at 8:36 AM
News IconBristol-Myers Squibb Company (BMY) Gain Traction from Its Virology Portfolio? - Smаrt Stоck Nеws (NYSE:BMY)
www.smartstocknews.com - September 10 at 3:46 PM
News IconRetreated Stocks in Focus- Bristol-Myers Squibb Company (NYSE ... - Seneca Globe (NYSE:BMY)
www.senecaglobe.com - September 9 at 3:50 PM
News IconThursday Trading Session Review: Bristol-Myers Squibb Company (NYSE:BMY) - National Daily Press (NYSE:BMY)
www.nationaldailypress.com - September 9 at 8:44 AM
News IconStocks Under Consideration: Bristol-Myers Squibb Co (NYSE:BMY), AK Steel Holding Corporation (NYSE:AKS), Vereit ... - NYSE Journal (press release) (NYSE:BMY)
stockznews.com - September 9 at 8:44 AM

Social

Bristol-Myers Squibb (NYSE:BMY) Chart for Monday, September, 26, 2016


Last Updated on 9/26/2016 by MarketBeat.com Staff